A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer.
Vous n'êtes pas connecté
A research team at the Medical University of Vienna, Austria, led by Maria Sibilia has investigated a new combination therapy for melanoma and breast cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with the local application of Imiquimod. This combination showed promising results in topically accessible tumours like melanoma and breast [...]
A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer.
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumours in...
Laboratorium: Russian scientists are developing a new method for identifying and treating cancers. The therapy aims to deliver medication directly to...
Researchers at the University of Pittsburgh have discovered a groundbreaking method to grow T cells in the lab that not only extends their lifespan...
27 January 2025 -- AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult...
Discover how copper impacts lung cancer growth and how copper chelation therapy could be a promising treatment.
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells...
A new study has found a way to treat patients with triple-negative breast cancer using a shorter and less toxic treatment plan while achieving similar...
Julia Bradbury recently shared the life-changing story of how her breast cancer was nearly missed twice, revealing the role that dense breast tissue...
On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk, a Trop-2-directed antibody and topoisomerase inhibitor...